Back to Browse Journals » Psoriasis: Targets and Therapy » Volume 2

The management of psoriasis through diet

Authors Duarte G, Barbosa LO, Rosa ME

Published Date August 2012 Volume 2012:2 Pages 45—53

DOI http://dx.doi.org/10.2147/PTT.S24755

Received 24 April 2012, Accepted 11 June 2012, Published 7 August 2012

Gleison Duarte,1 Luan Oliveira Barbosa,2 Maria Elisa A Rosa1

1Dermatology Division, Alergodermoclin, Salvador, Bahia, Brazil; 2Escola Bahiana de Medicina e Saúde Pública Salvador, Bahia, Brazil

Abstract: Diet is an important factor in the management of several dermatological diseases, such as dermatitis herpetiformis, acne vulgaris, gout, phrynoderma, pellagra, psoriasis, and acrodermatitis enteropathica. New concepts have emerged concerning the influence of diet on psoriasis. For example, diet has an adjuvant role in the management of several cardiovascular comorbidities that exhibit a higher-than-expected prevalence in psoriatic patients. Functional foods, such as yellow saffron and fish oil, may exert favorable effects on immune and cardiovascular functions. A gluten-free diet may promote significant clinical and histologic improvement. Folate supplementation may induce clinical improvement of psoriasis, but side effects may also occur. Diets rich in fresh fruits and vegetables are associated with a lower prevalence of psoriasis, and vegetarian diets were associated with clinical improvement. Additionally, many drug-diet interactions (retinoids, methotrexate, cyclosporine) must be considered in patients with psoriasis. Therefore, in addition to current nutritional advice given to psoriasis patients, further studies are necessary in the role of diet in psoriasis therapy.

Keywords: diet, lifestyle, psoriasis, recommendations, supplementation

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy

Flatz L, Conrad C

Psoriasis: Targets and Therapy 2013, 3:1-10

Published Date: 27 February 2013

Safety profiles of topical vitamin D3 in psoriasis patients: a retrospective large-scale study

Yamamoto A, Furuhashi T, Matsumoto K, Morita A

Psoriasis: Targets and Therapy 2012, 2:81-88

Published Date: 15 November 2012

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline

Levy LL, Solomon SM, Emer JJ

Psoriasis: Targets and Therapy 2012, 2:29-43

Published Date: 18 June 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011